Business Description
Shanghai Universal Biotech Co Ltd
ISIN : CNE100005709
Share Class Description:
SZSE:301166: Class ACompare
Compare
Traded in other countries / regions
301166.China IPO Date
2021-12-28Description
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 26.22 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.73 | |||||
| Interest Coverage | 23.72 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 8.35 | |||||
| Beneish M-Score | -1.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | -0.4 | |||||
| 3-Year Book Growth Rate | 70 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.11 | |||||
| 9-Day RSI | 40.1 | |||||
| 14-Day RSI | 40.81 | |||||
| 6-1 Month Momentum % | -18.43 | |||||
| 12-1 Month Momentum % | -36.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | |||||
| Quick Ratio | 9.83 | |||||
| Cash Ratio | 7.49 | |||||
| Days Inventory | 69.09 | |||||
| Days Sales Outstanding | 112.78 | |||||
| Days Payable | 21.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.23 | |||||
| Dividend Payout Ratio | 1.29 | |||||
| Forward Dividend Yield % | 3.23 | |||||
| 5-Year Yield-on-Cost % | 3.23 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.14 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.86 | |||||
| Operating Margin % | 3.44 | |||||
| Net Margin % | 5.56 | |||||
| FCF Margin % | -8.73 | |||||
| ROE % | 3.16 | |||||
| ROA % | 2.81 | |||||
| ROIC % | 5.18 | |||||
| ROC (Joel Greenblatt) % | 13.18 | |||||
| ROCE % | 3.52 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.09 | |||||
| PE Ratio without NRI | 40.45 | |||||
| PEG Ratio | 1.97 | |||||
| PS Ratio | 2.01 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| EV-to-EBIT | 13.34 | |||||
| EV-to-EBITDA | 13.34 | |||||
| EV-to-Revenue | 0.83 | |||||
| EV-to-FCF | -9.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.39 | |||||
| Price-to-Graham-Number | 1.43 | |||||
| Price-to-Net-Current-Asset-Value | 1.28 | |||||
| Price-to-Net-Cash | 1.97 | |||||
| Earnings Yield (Greenblatt) % | 7.5 | |||||
| FCF Yield % | -4.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Universal Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,219.553 | ||
| EPS (TTM) (Â¥) | 0.78 | ||
| Beta | 0 | ||
| Volatility % | 30.29 | ||
| 14-Day RSI | 40.81 | ||
| 14-Day ATR (Â¥) | 1.127089 | ||
| 20-Day SMA (Â¥) | 29.3145 | ||
| 12-1 Month Momentum % | -36.11 | ||
| 52-Week Range (Â¥) | 22.81 - 50.39 | ||
| Shares Outstanding (Mil) | 86.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Universal Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Universal Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Universal Biotech Co Ltd Frequently Asked Questions
What is Shanghai Universal Biotech Co Ltd(SZSE:301166)'s stock price today?
The current price of SZSE:301166 is ¥27.95. The 52 week high of SZSE:301166 is ¥50.39 and 52 week low is ¥22.81.
When is next earnings date of Shanghai Universal Biotech Co Ltd(SZSE:301166)?
The next earnings date of Shanghai Universal Biotech Co Ltd(SZSE:301166) is .
Does Shanghai Universal Biotech Co Ltd(SZSE:301166) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Universal Biotech Co Ltd(SZSE:301166) is 3.23% (As of Today), Highest Dividend Payout Ratio of Shanghai Universal Biotech Co Ltd(SZSE:301166) was 1.29. The lowest was 0.51. And the median was 0.51. The  Forward Dividend Yield % of Shanghai Universal Biotech Co Ltd(SZSE:301166) is 3.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers